Efficacy of Entecavir therapy in elderly patients with chronic hepatitis B infection

被引：0
|
作者：
Tan, You-wen [1 ,2 ]
Ge, Guo-hong [2 ]
Sun, Li [2 ]
Zhou, Xing-bei [2 ]
Peng, Pen-li [2 ]
Chen, Li [2 ]
机构：
[1] Soochow Univ, Affiliated Hosp 1, Dept Infect Dis, Suzhou, Jiangsu, Peoples R China
[2] 3 Peoples Hosp Zhenjiang, Dept Infect Dis, Zhenjiang, Jiangsu, Peoples R China
来源：
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES | 2014年 / 18卷 / 06期
关键词：
LAMIVUDINE;
D O I：
10.1016/j.bjid.2014.05.016
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：691 / 692
页数：2
相关论文
共 50 条
  • [11] The efficacy of entecavir therapy in nucleos(t)ide-naive patients with chronic hepatitis B
    Kim, J-W
    Park, N. H.
    Shin, J. W.
    Jung, S. W.
    Oh, S. Y.
    Lee, S. J.
    Lee, J. E.
    Jeong, I. D.
    Bang, S-J
    Kim, D. H.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A189 - A189
  • [12] The impact of cirrhosis on the efficacy and safety of entecavir for patients with chronic hepatitis B
    Huang, Rui
    Wang, Jian
    Zhao, Xiang-An
    Xia, Juan
    Wu, Chao
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (11) : 1314 - 1314
  • [13] Entecavir (Baraclude) in patients with chronic hepatitis B virus (HPV) infection
    Sacchi, Viola
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2008, 9 (03) : 157 - 161
  • [14] Comparable efficacy with entecavir monotherapy and tenofovir-entecavir combination in chronic hepatitis B patients
    Baqai, Sumbella
    Proudfoot, James
    Xu, Ronghui
    Kane, Steve
    Clark, Margaret
    Gish, Robert
    BMJ OPEN GASTROENTEROLOGY, 2015, 2 (01):
  • [15] Safety and efficacy of oral entecavir given for 28 days in patients with chronic hepatitis B virus infection
    de Man, RA
    Wolters, LMM
    Nevens, F
    Chua, D
    Sherman, M
    Lai, CL
    Gadano, A
    Lee, Y
    Mazzotta, F
    Thomas, N
    DeHertogh, D
    HEPATOLOGY, 2001, 34 (03) : 578 - 582
  • [16] Development of entecavir: Superior therapy for the management of chronic hepatitis B viral infection
    DeHertogh, D
    Colonno, R
    Fiske, W
    Cross, A
    THERAPY FOR VIRAL HEPATITIS AND PREVENTION OF HEPATOCELLULAR CARCINOMA, 2004, : 63 - 73
  • [17] The Efficacy and Safety of Entecavir and Interferon Combination Therapy for Chronic Hepatitis B Virus Infection: A Meta-Analysis
    Xie, Qiao-Ling
    Zhu, Ying
    Wu, Ling-Hong
    Fu, Lin-Lin
    Xiang, Yan
    PLOS ONE, 2015, 10 (07):
  • [18] Comparison of efficacy and renal safety of telbivudine and entecavir in treatment-naive elderly patients with chronic hepatitis B
    Law, Siu-tong
    Lee, Ming Kai
    Li, Kin Kong
    Mok, Chun Keung
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (02) : 193 - 198
  • [19] EFFICACY OF DIFFERENT NUCLEOSIDE ANALOG RESCUE THERAPY IN ENTECAVIR-RESISTANT CHRONIC HEPATITIS B PATIENTS
    Shang, Jin
    Zhou, Juan
    Liu, Huan
    Bai, Lang
    Tang, Hong
    HEPATOLOGY, 2020, 72 : 482A - 482A
  • [20] Efficacy of three years of continuous entecavir therapy in treatment-naive chronic hepatitis B patients
    Yang, S. Y.
    Kim, H. J.
    Lee, H. W.
    Cha, B. K.
    Song, I. D.
    Kim, S. W.
    Heo, C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 159 - 159
12345